Analyst Ratings for Marrone Bio Innovations (MBII)

MBII Rating Summary

MBII Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MBII
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $2.27 (+21.2%) * Over Last 12-Mos
Rating Score: 7.5 / 10   Percentile Rank: 78%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/28/2020 Canaccord Genuity Bobby Burleson New Coverage Buy
(N/A)
1.80
(N/A)
1.15
(1.87)
62.61% Details
7/24/2019 Aegis Capital
» Updated 2/11/2021
Nathan Weinstein New Coverage Buy
(N/A)
3.50
(1.65)
1.37
(1.87)
36.5% Details
Like MBII Ratings? Also take a look at PESI, ORGS, GMBL, MCD

MBII Ratings News